What is the official ID of this bill?
The official print number for this legislation is HR 3085.
Increased Diversity in Alzheimer's Disease Research
This act aims to increase the participation of individuals from minority groups in Alzheimer's disease clinical trials. This means research will better reflect the diversity of the population, potentially leading to more effective treatments for everyone. New research centers will be established in areas with higher concentrations of minority groups, along with diagnostic and treatment clinics tailored to their needs.
Key points
More Alzheimer's research will be conducted in areas with higher concentrations of minority groups, including at historically minority-serving institutions.
New diagnostic and treatment clinics will be established to meet the special needs of minority and rural populations.
Public outreach and education efforts will be expanded to encourage minority group members to participate in clinical trials.
Research will actively seek out principal investigators and researchers from underrepresented populations.
Eligibility criteria for clinical trials will be adjusted to allow broader patient participation, including older adults and those with mild disease.
Remote health technologies like telehealth will be used to reduce barriers to participation for minority groups.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.